Please login to the form below

Not currently logged in
Email:
Password:

Concordia

This page shows the latest Concordia news and features for those working in and with pharma, biotech and healthcare.

Concordia accused of overcharging NHS for thyroid drug

Concordia accused of overcharging NHS for thyroid drug

Markets Authority (CMA), which says Concordia “abused its dominant position to overcharge the NHS”. ... Concordia said it is “working to better understand the CMA's position and will continue to work constructively to resolve these matters”.

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Pharma deals in September 2015 Pharma deals in September 2015

    Transformational deals. The two largest deals announced this month were Cinven's sale of Amdipharm Mercury (AMCo) to Concordia Healthcare and Actelion's move to acquire ZS Pharma, at $3.5bn ... level. AMCo's commercial footprint reaches across 100

  • Medius Deal Watch table for March 2015 Medius Deal Watch table for March 2015

    J&J divest subsidiary marketing vascular devices. 1, 944. Covis / Concordia.

  • Pharma deals in March 2015 Pharma deals in March 2015

    Covis (asset). Concordia. 1.2. 8.2. NR. Hyperion. Horizon. 1.1. 9.6. 35%.

  • Deal Watch table for March 2014 Deal Watch table for March 2014

    341. Revive Pharmaceuticals/ Concordia Healthcare. Product acquisition. Donnatal, adjunctive therapy for IBS and acute enterocolitis (marketed).

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics